Annual General Meeting of Fresenius SE: Fresenius Confirms Positive Outlook for 2008 – 15th Consecutive Dividend Increase Approved

Following the Company's record financial results in 2007, Fresenius continues to expect strong sales and earnings growth in 2008. At the Annual General Meeting in Frankfurt Fresenius' Chairman of the Management Board Dr. Ulf M. Schneider confirmed the positive outlook for the full year 2008. Fresenius expects Group sales to increase by 8 to 10% in constant currency. Net income is expected to increase by 10 to 15% in constant currency. "Our growth prospects and strategic opportunities are excellent. The strong demand for high-quality healthcare drives sustainable organic growth. Selective acquisitions will further support our international business expansion. We are well positioned to take advantage of the opportunities in the fast-growing healthcare market," Schneider said.

During the Annual General Meeting, Fresenius shareholders approved the 15th consecutive dividend increase with a majority of more than 99%. Holders of ordinary shares will receive € 0.66 per share (2006: € 0.57) and holders of preference shares will receive € 0.67 (2006: € 0.58). This is an increase of about 15%. The total dividend distribution is € 103.2 million (2006: € 88.8 million).

Shareholders also elected a new supervisory board. Strategy Consultant Prof. Dr. h.c. Roland Berger and Klaus-Peter Müller, Chairman of the Supervisory Board of Commerzbank AG, will join the twelve-member board.


89.72 percent of the ordinary share capital and 59.17 percent of the preference share capital was represented at Fresenius SE's Annual General Meeting. A broad majority of more than 99 percent approved the actions of the Management and Supervisory Boards in 2007.